Rep. Clyde, Sen. Rubio Seek Answers On Pharmacy Distribution Of Abortion Drug
February 02, 2023
February 02, 2023
WASHINGTON, Feb. 2 -- Rep. Andrew Clyde, R-Georgia, issued the following news release and letter:
Congressman Andrew Clyde (GA-09) and Senator Marco Rubio (R-FL) sent a letter to the Government Accountability Office (GAO) Comptroller General Gene Dodaro urging the GAO to evaluate if the U.S. Food and Drug Administration's (FDA) new mifepristone policy change is considered a "rule" and subject to congressional review under the Congressional Review Act.
On . . .
Congressman Andrew Clyde (GA-09) and Senator Marco Rubio (R-FL) sent a letter to the Government Accountability Office (GAO) Comptroller General Gene Dodaro urging the GAO to evaluate if the U.S. Food and Drug Administration's (FDA) new mifepristone policy change is considered a "rule" and subject to congressional review under the Congressional Review Act.
On . . .